Navigation Links
Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance
Date:10/31/2011

BRAINTREE, Mass., Oct. 31, 2011 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported second quarter 2012 GAAP net revenues of $179.4 million, up 8%, net income of $13.9 million, down 35%, and earnings per share of $0.54, down 36%.  Excluding transformation costs and contingent consideration income, adjusted second quarter net income was $18.7 million, down 7%, and adjusted earnings per share was $0.72, down 9%.  Excluding currency impacts, net revenue was up 6% in the quarter.(1)

Year to date, Haemonetics reported GAAP net revenues of $350.0 million, up 6%, net income of $30.8 million, down 22%, and earnings per share of $1.18, down 23%.  Excluding transformation costs and contingent consideration income, adjusted first half net income was $35.8 million, down 9% and adjusted earnings per share was $1.37, down 11%.  Excluding currency impacts, first half fiscal 2012, net revenue was up 4%.(1)

Brian Concannon, Haemonetics' President and CEO, said: "The quality issues with the OrthoPAT® device recall and HS Core Bowl continued to negatively impact our operating income and earnings per share in the second quarter.  We have determined the root cause for both products, and remediation and recovery plans are well underway.  However, we have now concluded that we underestimated the costs to remediate and the impact that dealing with the quality issues had on elements of our business.  Our revised guidance fully reflects our learning.  We expect to put these issues behind us by the end of the fiscal year."

STRATEGIC AND SEGMENT GROWTH HIGHLIGHTSHaemonetics continues to make progress expanding its business.  The Company reported the following second quarter fiscal 12 highlights:

  • 14% revenue growth in plasma disposables, as increasing collection volumes drives revenues.
  • 7% revenue growth in t
    '/>"/>

  • SOURCE Haemonetics Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011
    2. Haemonetics Sets Date for Fourth Quarter Fiscal Year 2011 Earnings Release: May 2, 2011
    3. Haemonetics to Present at J.P. Morgan Healthcare Conference
    4. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
    5. Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results
    6. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
    7. HeartWare International Reports Third Quarter 2011 Revenues of $21.3 Million; 54% Increase From $13.8 Million in Third Quarter 2010
    8. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
    9. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2011
    10. ERT Reports Third Quarter 2011 Operating Results
    11. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ) ... Mammography Market - Growth, Trends And Forecasts (2014 - ... Mammography is a detailed type of imaging that customs ... exam, called a mammogram, is used to support in ... women. An x-ray (radiograph) is a noninvasive medical test ...
    (Date:5/27/2015)... Donatelli, a senior marketing associate with the animal health division of Eli ... a healthcare setting in Bangkok, Thailand , will be ... need with respect and dignity is the guiding star for me and ... in a LillyPad blog . Donatelli and Lilly colleagues ... Colombia , France , Ukraine ...
    (Date:5/27/2015)... May 25, 2015 Research and Markets ... addition of the "2015 Strategies in the ... offering. This comprehensive five-country report contains ... help current suppliers and potential market entrants identify ... coagulation testing market during the next five years. ...
    Breaking Medicine Technology:Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3European Coagulation Testing Market Strategies 2015 2
    ... TARRYTOWN, N.Y., Feb. 28, 2011 Regeneron Pharmaceuticals, Inc. ... a second Phase 3 study (PRE-SURGE 2) in gout ... and all secondary study endpoints. The primary endpoint was ... 16-week treatment period. Patients who received ARCALYST at a ...
    ... MYL ) today announced that its subsidiary Matrix ... and Drug Administration (FDA) for its Abbreviated New Drug Application ... 400 mg, the generic version of Pfizer,s Neurontin ® ... Gabapentin Capsules had U.S. sales of approximately $300 ...
    Cached Medicine Technology:ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 2ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 3ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 4ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 5ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 6ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 7ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 8ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 9ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 10
    (Date:5/28/2015)... 28, 2015 Orem, UT—Dymicron, Inc., (dymicron.com) ... using their unique Triadyme-C cervical total disc replacement device. ... William D. Smith at the American Institute of Minimally ... are responding well to the implantation of the Dymicron ... Spine Center and Chief of Neurosurgery for the University ...
    (Date:5/28/2015)... Career Step, an online provider of ... that Career Step Executive Vice President Mike Hodgson will ... presented by ICD10monitor in conjunction with Kimberly J. Carr ... and Ms. Carr will be discussing the importance of ... , “We have worked closely with HRS on a ...
    (Date:5/28/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national ... announced that it will participate as an exhibitor at ... to be held June 9-14, 2015 in New Orleans, ... opportunities, and exhibits with products and services. , ... will be available to speak with attendees about its ...
    (Date:5/28/2015)... 28, 2015 Atlanta-based Thrive Senior Living ... ground this summer on an innovative new Assisted Living ... engagement and connectivity in a unique, resort-like environment, Thrive ... technology and southern hospitality to create a distinctive experience ... unit community will feature luxuriously appointed resident apartments, a ...
    (Date:5/28/2015)... 28, 2015 Peggy J. Lynam, PT, DPT, ... the American Physical Therapy Association House of Delegates for the ... their Delegate Assembly. This will be her second term. ... as coordinator and principle spokesperson for the Chapter delegation and ... Directors or Delegate Assembly may direct the Chief Delegate to ...
    Breaking Medicine News(10 mins):Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Career Step and HRS Hosting June 4 ICD10monitor Webinar on the Importance of Auditing and Physician Training for ICD-10 Success 2Health News:Career Step and HRS Hosting June 4 ICD10monitor Webinar on the Importance of Auditing and Physician Training for ICD-10 Success 3Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2Health News:Thrive Announces Innovative New Senior Living Community in Huntsville, AL 2
    ... ... all fields of the dental profession will come together to share knowledge and explore innovations ... ... second in a series of unique conferences offering high-quality scientific programs, which broaden perspectives by ...
    ... , SATURDAY, June 19 (HealthDay News) -- A pair ... of vitamin D could lead to poor blood sugar ... metabolic syndrome among seniors. , Both findings are slated ... meeting in San Diego. , In one study, researchers ...
    ... ... will launch their first home care product – the advanced water purifier and energiser, ... , ... 19, 2010 -- QuestNet , an international direct selling and network marketing company, ...
    ... ... Women’s Answer to a Male Dominated Gym scene. Embody Pole gives the women of the ... ... physical fitness were completely male-centered. Where do women go when they want to work out ...
    ... ... in to Super Meals , ... Pompano Beach, FL (PRWEB) June 18, 2010 -- Hit morning show airing on Lifetime Television ... shelf-stable seafood in a search for the Chicken of the Sea SuperCook, someone who can ...
    ... of being a good dad, expert suggests , FRIDAY, June ... their new ties and other tokens of gratitude, they might ... gift: a promise that they,ll watch their health, suggests a ... men die younger than women and are more likely to ...
    Cached Medicine News:Health News:The 2nd Future Trends in Implantology International Dental Conference 2Health News:Vitamin D Deficiency Linked to Diabetes, Metabolic Syndrome in Studies 2Health News:QuestNet to Launch its First Home Care Product 2Health News:QuestNet to Launch its First Home Care Product 3Health News:“Embody Pole Fitness” Puts a Sexy Spin on Fitness in the Inland Empire 2Health News:'The Balancing Act' & Chicken of the Sea Search for America's 'Supercook' 2Health News:'The Balancing Act' & Chicken of the Sea Search for America's 'Supercook' 3Health News:On Father's Day, Give Dad Gift of Health 2
    The ENDO MINI-RETRACT™ 5 mm instrument has application in a variety of gynecologic, abdominal, urologic, thoracic and endoscopic procedures for temporary retraction of tissue and small tubular ...
    ... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
    Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
    Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
    Medicine Products: